Showing results (141-150 of 11,019) with videos related to
Sort By:
Pageof 1,102
Diabetes, Obesity & Metabolism|January 10, 2018
Have we really demonstrated the cardiovascular safety of anti-hyperglycaemic drugs? Rethinking the concepts of macrovascular and microvascular disease in type 2 diabetesMilton PackerEuropean Journal of Heart Failure|March 23, 2018
Are the effects of drugs to prevent and to treat heart failure always concordant? The statin paradox and its implications for understanding the actions of antidiabetic medicationsMilton PackerEuropean Journal of Heart Failure|December 19, 2018
The conundrum of patients with obesity, exercise intolerance, elevated ventricular filling pressures and a measured ejection fraction in the normal rangeMilton PackerInternational Journal of Cardiology|March 18, 2018
Inferential characterization of the dose-response relationships of neurohormonal antagonists in chronic heart failure: A novel approach based on large-scale trials with active comparatorsMilton PackerJournal of the American Heart Association|August 14, 2020
Molecular, Cellular, and Clinical Evidence That Sodium-Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart FailureMilton PackerPsychiatry|January 20, 2009
A model for interpretative supportive dynamic psychotherapyMilton ViedermanJournal of the American Society of Nephrology : JASN|June 21, 2023
Fetal Reprogramming of Nutrient Surplus Signaling, O-GlcNAcylation, and the Evolution of CKDMilton PackerCirculation. Heart Failure|September 8, 2020
Cardioprotective Effects of Sirtuin-1 and Its Downstream Effectors: Potential Role in Mediating the Heart Failure Benefits of SGLT2 (Sodium-Glucose Cotransporter 2) InhibitorsMilton PackerCirculation|March 14, 2020
Role of Deranged Energy Deprivation Signaling in the Pathogenesis of Cardiac and Renal Disease in States of Perceived Nutrient OverabundanceMilton PackerDiabetes, Obesity & Metabolism|February 23, 2018
Higher mortality rate in patients with heart failure who are taking commonly prescribed antidiabetic medications and achieve recommended levels of glycaemic controlMilton PackerPageof 1,102